Cargando…

Serum microRNAs are altered in various stages of chronic kidney disease: a preliminary study

Mostrar otras versiones (1)

BACKGROUND: MicroRNAs (miRNAs) are innovative and informative blood-based biomarkers involved in numerous pathophysiological processes. In this study and based on our previous experimental data, we investigated miR-126, miR-143, miR-145, miR-155 and miR-223 as potential circulating biomarkers for th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brigant, Benjamin, Metzinger-Le Meuth, Valérie, Massy, Ziad A., McKay, Nathalie, Liabeuf, Sophie, Pelletier, Marion, Sallée, Marion, M'Baya-Moutoula, Eléonore, Paul, Pascale, Drueke, Tilman B., Burtey, Stéphane, Metzinger, Laurent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Biomarkers in CKD
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469576/ https://www.ncbi.nlm.nih.gov/pubmed/28643818 http://dx.doi.org/10.1093/ckj/sfw060

Ejemplares similares

Serum microRNAs are altered in various stages of chronic kidney disease: a preliminary study
por: Brigant, Benjamin, et al.
Publicado: (2017)

miR-126 Is Involved in Vascular Remodeling under Laminar Shear Stress
por: Mondadori dos Santos, Ana, et al.
Publicado: (2015)

Inorganic Phosphate Accelerates the Migration of Vascular Smooth Muscle Cells: Evidence for the Involvement of miR-223
por: Rangrez, Ashraf Yusuf, et al.
Publicado: (2012)

Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients
por: Fourdinier, Ophélie, et al.
Publicado: (2019)

Serum osteoprotegerin and renal function in the general population: the Tromsø Study
por: Vik, Anders, et al.
Publicado: (2017)

Circulating miRNAs as biomarkers of kidney disease
por: Hüttenhofer, Alexander, et al.
Publicado: (2017)

TRIMming down to TRIM37: Relevance to Inflammation, Cardiovascular Disorders, and Cancer in MULIBREY Nanism
por: Brigant, Benjamin, et al.
Publicado: (2018)

Novel insights into parathyroid hormone: report of The Parathyroid Day in Chronic Kidney Disease
por: Ureña-Torres, Pablo A, et al.
Publicado: (2018)

Achievement of Kidney Disease: Improving Global Outcomes mineral and bone targets between 2010 and 2014 in incident dialysis patients in France: the Photo-Graphe3 study
por: Fouque, Denis, et al.
Publicado: (2018)

Achievement of 2009 and 2017 Kidney Disease: Improving Global Outcomes mineral and bone targets and survival in a French cohort of chronic kidney disease Stages 4 and 5 non-dialysis patients
por: Fouque, Denis, et al.
Publicado: (2018)

The European Renal Association – European Dialysis and Transplant Association Registry Annual Report 2014: a summary
por: Pippias, Maria, et al.
Publicado: (2017)

Protein-Bound Uremic Toxins: New Insight from Clinical Studies
por: Liabeuf, Sophie, et al.
Publicado: (2011)

Syndecan-1 and Free Indoxyl Sulfate Levels Are Associated with miR-126 in Chronic Kidney Disease
por: Fourdinier, Ophélie, et al.
Publicado: (2021)

Renal artery intervention utilizing carbon dioxide angiography
por: Sag, Alan A, et al.
Publicado: (2017)

Symptom burden in patients with chronic kidney disease not requiring renal replacement therapy
por: Brown, Stephanie A, et al.
Publicado: (2017)

Renal denervation using carbon dioxide renal angiography in patients with uncontrolled hypertension and moderate to severe chronic kidney disease
por: Hameed, Mohammed Awais, et al.
Publicado: (2017)

Patterns of progression of chronic kidney disease at later stages
por: Caravaca-Fontán, Fernando, et al.
Publicado: (2018)

The relationship between kidney function and quality of life among community-dwelling adults varies by age and filtration marker
por: Canney, Mark, et al.
Publicado: (2018)

Frailty and chronic kidney disease: current evidence and continuing uncertainties
por: Nixon, Andrew C, et al.
Publicado: (2018)

A scheme based on ICD-10 diagnoses and drug prescriptions to stage chronic kidney disease severity in healthcare administrative records
por: Friberg, Leif, et al.
Publicado: (2018)

Incorporating patient-reported symptom assessments into routine care for people with chronic kidney disease
por: van der Veer, Sabine N, et al.
Publicado: (2017)

The metabolomic quest for a biomarker in chronic kidney disease
por: Davies, Robert
Publicado: (2018)

Current trends in European renal epidemiology
por: Heaf, James
Publicado: (2017)

Low lean tissue mass is an independent risk factor for mortality in patients with stages 4 and 5 non-dialysis chronic kidney disease
por: Vega, Almudena, et al.
Publicado: (2017)

Quality of life with conservative care compared with assisted peritoneal dialysis and haemodialysis
por: Iyasere, Osasuyi, et al.
Publicado: (2018)

Clarifying the concept of chronic kidney disease for non-nephrologists
por: Perez-Gomez, Maria Vanessa, et al.
Publicado: (2019)

Impact of a phone app on nephrology referral
por: Oliva-Damaso, Nestor, et al.
Publicado: (2018)

Chronic kidney disease and urological disorders: systematic use of uroflowmetry in nephropathic patients
por: Lai, Silvia, et al.
Publicado: (2018)

Anticoagulant-related nephropathy: systematic review and meta-analysis
por: de Aquino Moura, Karolinny Borinelli, et al.
Publicado: (2019)

Single-dose sodium polystyrene sulfonate for hyperkalemia in chronic kidney disease or end-stage renal disease
por: Hunt, Taylor V, et al.
Publicado: (2018)

Obesity and chronic kidney disease progression—the role of a new adipocytokine: C1q/tumour necrosis factor-related protein-1
por: Barbieri, Diego, et al.
Publicado: (2018)

Is polypharmacy an increasing burden in chronic kidney disease? The German experience
por: Parker, Kathrine, et al.
Publicado: (2019)

Patterns of medication use and the burden of polypharmacy in patients with chronic kidney disease: the German Chronic Kidney Disease study
por: Schmidt, Insa M, et al.
Publicado: (2019)

Circulating active von Willebrand factor levels are increased in chronic kidney disease and end-stage renal disease
por: van der Vorm, Lisa N, et al.
Publicado: (2019)

Non-steroidal anti-inflammatory drugs in chronic kidney disease: a systematic review of prescription practices and use in primary care
por: Lefebvre, Claire, et al.
Publicado: (2019)

Indole 3-acetic acid, indoxyl sulfate and paracresyl-sulfate do not influence anemia parameters in hemodialysis patients
por: Bataille, Stanislas, et al.
Publicado: (2017)

miR-223 and other miRNA's evaluation in chronic kidney disease: Innovative biomarkers and therapeutic tools
por: Metzinger-Le Meuth, Valérie, et al.
Publicado: (2019)

Les atteintes rénales de la COVID-19
por: Burtey, Stéphane, et al.
Publicado: (2021)

Uremic Toxins Affect Erythropoiesis during the Course of Chronic Kidney Disease: A Review
por: Hamza, Eya, et al.
Publicado: (2020)

The Role of Non-Coding RNAs in Kidney Diseases
por: Metzinger, Laurent, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gruh693noife1tsgahrb25rs9d